Pharmacological properties and discriminative stimulus effects of a novel and selective 5-HT2 receptor agonist AL-38022A [(S)-2-(8,9-dihydro-7H-pyrano[2,3-g]indazol-1-yl)-1-methylethylamine].

Pharmacology, Biochemistry, and Behavior
Jesse A MayCharles P France

Abstract

AL-38022A is a novel synthetic serotonergic (5-HT) ligand that exhibited high affinity for each of the 5-HT2 receptor subtypes (Ki<or=2.2 nM), but a significantly lower (>100-fold less) affinity for other 5-HT receptors. In addition, AL-38022A displayed a very low affinity for a broad array of other receptors, neurotransmitter transport sites, ion channels, and second messenger elements, making it a relatively selective agent. AL-38022A potently stimulated functional responses via native and cloned rat (EC50 range: 1.9-22.5 nM) and human (EC50 range: 0.5-2.2 nM) 5-HT2 receptor subtypes including [Ca2+]i mobilization and tissue contractions with apparently similar potencies and intrinsic activities and was a full agonist at all 5-HT2 receptor subtypes. The CNS activity of AL-38022A was assessed by evaluating its discriminative stimulus effects in both a rat and a monkey drug discrimination paradigm using DOM as the training drug. AL-38022A fully generalized to the DOM stimulus in each of these studies; in monkeys MDL 100907 antagonized both DOM and AL-38022A. The pharmacological profile of AL-38022A suggests that it could be a useful tool in defining 5-HT2 receptor signaling and receptor characterization where 5-HT may function ...Continue Reading

References

Dec 1, 1985·Pharmacology, Biochemistry, and Behavior·R A Glennon, A E Hauck
Jan 1, 1986·Medicinal Research Reviews·R Young, R A Glennon
Dec 1, 1995·Trends in Pharmacological Sciences·W P Bowen, J C Jerman
Oct 6, 2001·Journal of Cardiovascular Pharmacology·S W WattsM Baez
Apr 5, 2003·The Journal of Pharmacology and Experimental Therapeutics·Jesse A MayThomas R Dean
Feb 6, 2004·Pharmacology & Therapeutics·David E Nichols
Jan 6, 2005·The Journal of Biological Chemistry·Elodie Archer-LahlouDaniel Fourmy
Jan 2, 2007·The Journal of Clinical Psychiatry·Francisco A MorenoPedro L Delgado

❮ Previous
Next ❯

Citations

Jul 19, 2014·Behavioural Brain Research·Adam L Halberstadt
Jan 26, 2018·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Ya Fatou Njie-MbyeNaj Sharif
Jan 25, 2018·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Sunny E OhiaNaj A Sharif

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.